Daniel O'Day

CV as per end of term

Nationality
American

Year of Birth
1964

CEO Roche Pharmaceuticals

1987-1995
Roche Pharma, US, Various commercial/sales roles

1995
Roche Pharma, US, Director Human Resources

1996
Roche Pharma, US, Director Product Marketing

1998
Roche Pharma HQ, Switzerland, Head Business Unit, Arthritis and Respiratory

1999
Roche Pharma HQ, Switzerland, Lifecycle Leader Tamiflu

2001
Roche Pharma, Japan, Head Corporate Planning, Tokyo

2003
Roche Pharma, Denmark, General Manager

2006
Roche Molecular Diagnostics (RMD), Pleasanton, US, President & CEO

2010
Roche Diagnostics Division, Chief Operating Officer and Member of the Roche Corporate Executive Committee

2012
Roche Pharmaceuticals Division, COO and Member of the Roche Corporate Executive Committee

Discover more

Our approach to sustainability governance
About Roche
As sustainability is built into our business strategy, a shared commitment from all business areas and senior management is reflected in our sustainability governance structure.
Code of conduct
About Roche
The Roche Group Code of Conduct states the expectations Roche as an employer has towards his employees and sets forth the standards for business behaviour that apply throughout the Roche Group.
Investors
Investors
We are committed to delivering value for all our stakeholders through continuous innovation, groundbreaking solutions, trust and sustainable business practices.
Board Committees
About Roche
Our Board of Directors has delegated certain matters to four committees for detailed attention.
Executive Committee
About Roche
The Executive Committee's composition and the curricula vitae of its members.
Articles of Incorporation & Bylaws
About Roche
Our Articles of Incorporation contain the principal information on Roche's business purpose, structures and statutory bodies.